We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$27.8B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+31.84%
1 Year Est. Return
+46.46%
3 Year Est. Return
+129.16%
5 Year Est. Return
+174.16%
10 Year Est. Return
+698%
AUM
$27.8B
AUM Growth
+$4.02B
(+17%)
Cap. Flow
-$324M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
27.66%
Holding
1,111
New
158
Increased
319
Reduced
438
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
SNDK
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCC
901
WESCO International
WCC
$17.1B
| $234K | ﹤0.01% |
+678
| New | +$230K |
|
902
Nkarta
NKTX
$209M
| $234K | ﹤0.01% |
+82,658
| New | +$233K |
|
903
Crawford & Co Class A
CRD.A
$632M
| $232K | ﹤0.01% |
20,605
+6,820
| +49% | +$72.5K |
|
904
SkinHealth Systems
SKIN
$89.1M
| $227K | ﹤0.01% |
327,377
-16,182
| -5% | -$12.4K |
|
905
Intrepid Potash
IPI
$545M
| $219K | ﹤0.01% |
6,693
-1,529
| -19% | -$58.2K |
|
906
Janux Therapeutics
JANX
$1.24B
| $219K | ﹤0.01% |
+14,238
| New | +$206K |
|
907
Purple Innovation
PRPL
$16.6M
| $217K | ﹤0.01% |
24,327
| – | – |
|
908
Ford
F
$58.3B
| $214K | ﹤0.01% |
+15,415
| New | +$208K |
|
909
Netflix
NFLX
$326B
| $206K | ﹤0.01% |
2,892
-553,090
| -99% | -$48.7M |
|
910
Macy's
M
$6.06B
| $203K | ﹤0.01% |
+8,599
| New | +$180K |
|
911
QuantumScape Corp
QS
$3.37B
| $195K | ﹤0.01% |
+25,752
| New | +$193K |
|
912
Metagenomi Therapeutics
MGX
$44.2M
| $190K | ﹤0.01% |
160,000
-222,153
| -58% | -$297K |
|
913
First Northwest Bancorp
FNWB
$105M
| $183K | ﹤0.01% |
16,897
-37
| -0.2% | -$369 |
|
|
ONL
914
Orion Office REIT
ONL
$155M
| $182K | ﹤0.01% |
62,914
-13,388
| -18% | -$36.7K |
|
|
AIV
915
Aimco
AIV
$372M
| $181K | ﹤0.01% |
60,990
-11,177
| -15% | -$42.8K |
|
|
NLOP
916
Net Lease Office Properties
NLOP
$163M
| $154K | ﹤0.01% |
13,867
| – | – |
|
917
ADC Therapeutics
ADCT
$174M
| $151K | ﹤0.01% |
+141,344
| New | +$412K |
|
918
Zevia
ZVIA
$98.8M
| $130K | ﹤0.01% |
79,488
-214,401
| -73% | -$291K |
|
919
Conduent
CNDT
$302M
| $125K | ﹤0.01% |
85,346
-1,045,679
| -92% | -$1.62M |
|
920
C4 Therapeutics
CCCC
$463M
| $117K | ﹤0.01% |
25,111
-239,509
| -91% | -$819K |
|
921
Silvercrest Asset Management
SAMG
$79.5M
| $116K | ﹤0.01% |
11,476
-1,464
| -11% | -$17.8K |
|
922
JELD-WEN Holding
JELD
$200M
| $114K | ﹤0.01% |
76,202
-1,817,799
| -96% | -$2.8M |
|
923
Chegg
CHGG
$94.5M
| $109K | ﹤0.01% |
107,598
-363,771
| -77% | -$399K |
|
924
PMV Pharmaceuticals
PMVP
$69M
| $94.5K | ﹤0.01% |
70,504
-109,369
| -61% | -$140K |
|
|
LENZ
925
LENZ Therapeutics
LENZ
$187M
| $91.2K | ﹤0.01% |
16,061
-100,950
| -86% | -$814K |
|
Similar funds
UIM
SSA
CAM
CM
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.